Comparative activity of carbapenem testing: the COMPACT study

In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study

(2010) K.J. Christiansen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa

(2009) Marc H. Scheetz et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pharmacokinetic–pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients

(2009) Scott A. Van Wart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections

(2009) Cristina Suárez et al.   JOURNAL OF INFECTION

Comparison of different methods of determining  -lactam susceptibility in clinical strains of Pseudomonas aeruginosa

(2009) E. Torres et al.   JOURNAL OF MEDICAL MICROBIOLOGY

MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates

(2008) Philip J. Turner   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pharmacokinetic–pharmacodynamic target attainment analysis of doripenem in infected patients

(2008) Kazuro Ikawa et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06

(2008) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites

(2008) D. Gur et al.   JOURNAL OF MEDICAL MICROBIOLOGY